5347 篇
13897 篇
477391 篇
16218 篇
11751 篇
3898 篇
6511 篇
1243 篇
75482 篇
37479 篇
12122 篇
1648 篇
2846 篇
3402 篇
641 篇
1237 篇
1970 篇
4900 篇
3855 篇
5414 篇
全球高血压药物市场报告(2016-2020年)
Global Hypertension Drugs Market 2016-2020
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
Key buying criteria
PART 05: Cardiovascular drugs market
Global pharmaceuticals market
Global cardiovascular drugs market
PART 06: Overview: Hypertension
Systemic hypertension
PAH
PART 07: Epidemiology and economic burden
Economic burden
PART 08: Pipeline portfolio
PART 09: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 10: Market segmentation by type
Global systemic hypertension drugs market
Global PAH drugs market
PART 11: Market segmentation by drug class
Systemic hypertension
PAH
PART 12: Geographical segmentation
Global hypertension drugs market by geographical
segmentation 2015-2020
Hypertension drugs market in Americas
Hypertension drugs market in EMEA
Hypertension drugs market in APAC
PART 13: Market drivers
Growing older population
Rise in sedentary lifestyle
High prevalence of chronic conditions
Patient assistance programs
PART 14: Impact of drivers
PART 15: Market challenges
Patent expiries of major drugs
Adverse effects
Poor patient compliance
Availability of alternative therapies
PART 16: Impact of drivers and challenges
PART 17: Market trends
Increase in awareness
Increased focus on combination therapies
Intense competition among vendors
Strategic alliances
PART 18: Vendor landscape
Competitive scenario
Market share 2015
Novartis
Daiichi Sankyo
Actelion Pharmaceuticals
Boehringer Ingelheim
Sanofi
AstraZeneca
Other prominent vendors
PART 19: Appendix
List of abbreviations
PART 20: Explore Technavio